FDA Authorizes Eli Lilly’s COVID-19 Antibody Therapy for Children

Contact Your Elected Officials
The Epoch Times Header

The Food and Drug Administration (FDA) on Friday expanded its emergency use authorization (EUA) of Eli Lilly and Co’s dual-antibody therapy for mild to moderate COVID-19 to all children, including newborns.

The treatment consists of bamlanivimab and etesevimab—two monoclonal antibodies that are administered by intravenous infusion. The two monoclonal antibodies are directed against the spike protein of SARS-CoV-2, to block the virus’s attachment and entry into human cells. They work by binding to different but overlapping sites on the spike protein.

The antibody treatment was first authorized for emergency use in February for people aged 12 years and older who weigh at least 88 pounds (40 kilograms), who have mild to moderate COVID-19 symptoms and are at high risk for progression to severe COVID-19, including hospitalization or death.

The FDA in September authorized use of the antibody therapy for post-exposure prevention of COVID-19 in the same population. The latest FDA authorization extends the treatment to all children, including newborns.

“Children under one year of age who are exposed to the virus that causes COVID-19 may be at particularly high risk for severe COVID-19 and this authorization addresses the medical needs of this vulnerable population,” Patrizia Cavazzoni, director of the FDA’s Center for Drug Evaluation and Research, said in a statement.

He asserted that the therapy “is not a substitute for vaccination.”

The FDA said a clinical trial including 125 children was conducted to assess the safety of the treatment, to support the authorization. Children weighing less than 88 pounds were administered doses of the monoclonal antibodies adjusted for their body weight.

“Serious adverse events including hypersensitivity, anaphylaxis, and infusion-related reactions have been observed with bamlanivimab with and without coadministration of etesevimab,” according to the FDA. “Possible side effects of bamlanivimab and etesevimab administered together include nausea, dizziness, pruritus, and rash.”

By Mimi Nguyen Ly

Read Original Article on TheEpochTimes.com

The Epoch Times
The Epoch Timeshttps://www.theepochtimes.com/
Tired of biased news? The Epoch Times is truthful, factual news that other media outlets don't report. No spin. No agenda. Just honest journalism like it used to be.

Why Democracy, not Caesar, is the answer to our problems

Caesar-style leadership wins quick public support but inevitably sparks passionate resistance, conflict, bloodshed, and lasting social destabilization.

WATCH: Barack Obama Foments Color Revolutions in Eastern Europe

Obama astroturfed “pro-democracy” movements in Poland and Hungary to pressure their govts into accepting mass migration and social engineering.

J.B. Pritzker Puts the ILLeagals in ILLinois

Illinois Gov. J.B. Pritzker, once a California native, has revived the old “ILL” abbreviation—this time in his promotion of ILLegal aliens.

James Franklin’s contract fallout

Penn State’s decision to fire head coach James Franklin after a disappointing 22–21 home loss to Northwestern will cost an estimated $56 million buyout. 

Trump’s Middle East Trip Led to Historic Breakthroughs

Trump’s bold, unconventional strategy helped end the Israel-Hamas war and set the stage for a more stable, prosperous Middle East.

Trump Commutes Sentence of Former Rep. George Santos

President Trump commuted ex-Rep. George Santos’s seven-year prison sentence for fraud and identity theft, ordering his immediate release.

Jack Smith Referred to DOJ for Misconduct Investigation and Possible Disbarment

Former special counsel Jack Smith was criminally referred to the DOJ by Republican lawmakers for alleged misconduct and possible disbarment.

AI Is a ‘Real and Mysterious Creature,’ Not a Predictable Machine, Anthropic Co-Founder Warns

Handling AI is like dealing with “a real and mysterious creature, not a predictable machine,” said Jack Clark, co-founder of Anthropic, at a Berkeley conference.

Trump Refiles $15 Billion Defamation Lawsuit Against New York Times After Court Dismissal

Trump refiled his $15 billion defamation lawsuit against The New York Times, Penguin Random House, and 3 reporters after judge dismissed the case.

Army Corps of Engineers to Pause $11 Billion in Projects During Shutdown: Vought

Russ Vought, director of the White House’s OMB, has added to the growing pile of federal projects paused during the government shutdown.

Trump Signs Executive Order Putting New Restrictions on Federal Hiring

Trump signed an executive order directing federal agencies to restrict hiring, with exceptions for immigration, security, and political appointees.

Trump Says He Has Authorized Covert CIA Operations in Venezuela

President Trump authorized covert CIA operations in Venezuela, expanding U.S. assets there to increase pressure on President Nicolás Maduro’s regime.

Trump Posthumously Awards Charlie Kirk the Presidential Medal of Freedom

President Trump posthumously awarded Charlie Kirk the Presidential Medal of Freedom in the White House Rose Garden on Oct 14, Charlie's birthday.
spot_img

Related Articles

Popular Categories

MAGA Business Central